Maravai Lifesciences Holdings (MRVI) Retained Earnings (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Retained Earnings of $466000.0 for Q1 2026, down 99.75% year-over-year from $186.8 million in Q1 2025, and down 11.07% quarter-over-quarter from $524000.0 in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Retained Earnings (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Retained Earnings history runs 7 years deep, the most recent figure standing at $466000.0 for Q1 2026.
- In Q1 2026, Retained Earnings fell 99.75% year-over-year to $466000.0; the TTM figure through Mar 2026 stood at $466000.0 (down 99.75% YoY), while the FY2025 annual figure was $524000.0, down 99.63% from the prior year.
- Retained Earnings for Q1 2026 stood at $466000.0, down from $524000.0 in the prior quarter.
- The five-year high for Retained Earnings was $404.8 million in Q4 2022, with the low at $466000.0 in Q1 2026.
- The 5-year median for Retained Earnings is $140.9 million (2024), against an average of $172.2 million.
- The sharpest annual moves came in 2022 and 2026: Retained Earnings jumped 401.77% in 2022, then tumbled 99.75% in 2026.
- Maravai Lifesciences Holdings' Retained Earnings stood at $404.8 million in 2022, then sank by 68.25% to $128.5 million in 2023, then increased by 9.64% to $140.9 million in 2024, then slumped by 99.63% to $524000.0 in 2025, then declined by 11.07% to $466000.0 in 2026.
- Business Quant data shows MRVI's Retained Earnings at $466000.0 in Q1 2026, $524000.0 in Q4 2025, and $579000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn | 207.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 207.60 Mn |
| Mar 31, 2026 | 466,000.00 |
| Dec 31, 2025 | 524,000.00 |
| Sep 30, 2025 | 579,000.00 |
| Jun 30, 2025 | 574,000.00 |
| Mar 31, 2025 | 186.80 Mn |
| Dec 31, 2024 | 140.89 Mn |
| Sep 30, 2024 | 166.80 Mn |
| Jun 30, 2024 | 168.34 Mn |
| Mar 31, 2024 | 273.66 Mn |
| Dec 31, 2023 | 128.50 Mn |
| Sep 30, 2023 | 125.09 Mn |
| Jun 30, 2023 | 398.16 Mn |
| Mar 31, 2023 | 114.31 Mn |
| Dec 31, 2022 | 404.77 Mn |
| Sep 30, 2022 | 367.13 Mn |
| Jun 30, 2022 | 322.66 Mn |
| Mar 31, 2022 | 128.58 Mn |
| Dec 31, 2021 | 184.56 Mn |
| Sep 30, 2021 | 173.09 Mn |